Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gay, J. C.
Right arrow Articles by Lukens, J. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gay, J. C.
Right arrow Articles by Lukens, J. N.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Modulation of neutrophil oxidative responses to soluble stimuli by platelet-activating factor

JC Gay, JK Beckman, KA Zaboy and JN Lukens

The role of platelet activating factor (PAF) as a regulator of human neutrophil superoxide (O2-) generation in response to soluble and particulate stimuli was examined. At concentrations greater than 10(-7) mol/L, PAF alone induced a brief burst of O2- production. When cells were exposed to PAF and either the chemotactic peptide n-formyl- methionyl-leucyl-phenylalanine (FMLP 10(-7) mol/L) or the tumor promoter phorbol myristate acetate (PMA 10 ng/mL), a marked synergistic augmentation of O2- release was noted when compared to control cells stimulated with FMLP or PMA alone. Mean percentage of enhancement by 10(-5) mol/L of PAF was 297% +/- 35% (n = 9) of control responses to FMLP and 185% +/- 16% (n = 3) of control responses to PMA. Consistent enhancement occurred with PAF concentrations of as low as 10(-9) mol/L. Enhancement could be demonstrated when neutrophils were exposed to PAF either at the same time as, or up to 60 minutes prior to, the second stimulus, and was neither reversed by removal of PAF from the medium prior to addition of FMLP or PMA nor dependent on the presence of extracellular divalent cations. Continuous recordings revealed that the enhancement was due to an increased maximal rate of O2- production. In contrast, PAF concentrations up to 10(-5) mol/L had only a minimal effect on the response to neutrophils to opsonized zymosan. Analysis of the enhancing properties of lipids structurally related to PAF revealed that the critical moiety was the saturated fatty acid at position 1. These results indicate the presence of a PAF-mediated positive feedback loop whereby the oxidative burst induced by some soluble stimuli is augmented. Modulation of neutrophil O2- production by PAF may serve to amplify neutrophil oxidative responses at sites of inflammation.

Volume 67, Issue 4, pp. 931-936, 04/01/1986
Copyright © 1986 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
S. Bluml, B. Rosc, A. Lorincz, M. Seyerl, S. Kirchberger, O. Oskolkova, V. N. Bochkov, O. Majdic, E. Ligeti, and J. Stockl
The Oxidation State of Phospholipids Controls the Oxidative Burst in Neutrophil Granulocytes
J. Immunol., September 15, 2008; 181(6): 4347 - 4353.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
F. H. Falcone, A. G. Rossi, R. Sharkey, A. P. Brown, D. I. Pritchard, and R. M. Maizels
Ascaris suum-Derived Products Induce Human Neutrophil Activation via a G Protein-Coupled Receptor That Interacts with the Interleukin-8 Receptor Pathway
Infect. Immun., June 1, 2001; 69(6): 4007 - 4018.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. Takahashi, F. Hato, T. Yamane, H. Fukumasu, K. Suzuki, S. Ogita, Y. Nishizawa, and S. Kitagawa
Activation of Human Neutrophil by Cytokine-Activated Endothelial Cells
Circ. Res., March 2, 2001; 88(4): 422 - 429.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. J. Zehr, R. S. Poston, P. C. Lee, K. Uthoff, P. Kumar, P. W. Cho, A. M. Gillinov, J. M. Redmond, J. A. Winkelstein, A. Herskowitz, et al.
Platelet Activating Factor Inhibition Reduces Lung Injury After Cardiopulmonary Bypass
Ann. Thorac. Surg., February 1, 1995; 59(2): 328 - 335.
[Abstract] [Full Text]


Home page
Arch SurgHome page
W. L. Biffl, E. E. Moore, F. A. Moore, V. S. Carl, F. J. Kim, and R. J. Franciose
Interleukin-6 Potentiates Neutrophil Priming With Platelet-Activating Factor
Arch Surg, November 1, 1994; 129(11): 1131 - 1136.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
J. B. Gupta, M. Prasad, J. Kalra, and K. Prasad
Platelet-Activating-Factor-Induced Changes in Cardiovascular Function and Oxyradical Status of Myocardium in Presence of the PAF Antagonist CV-6209
Angiology, January 1, 1994; 45(1): 25 - 36.
[Abstract] [PDF]


Home page
Arch SurgHome page
W. H. Horl, R. M. Schafer, M. Horl, and A. Heidland
Neutrophil Activation in Acute Renal Failure and Sepsis
Arch Surg, May 1, 1990; 125(5): 651 - 654.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
R. I. Lehrer, T. Ganz, M. E. Selsted, B. M. Babior, and J. T. Curnutte
Neutrophils and Host Defense
Ann Intern Med, July 15, 1988; 109(2): 127 - 142.
[Abstract] [PDF]


Home page
Arch SurgHome page
S. D. Tennenberg and J. S. Solomkin
Neutrophil Activation in Sepsis: The Relationship Between fMet-Leu-Phe Receptor Mobilization and Oxidative Activity
Arch Surg, February 1, 1988; 123(2): 171 - 175.
[Abstract] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1986 by American Society of Hematology         Online ISSN: 1528-0020